Introduction
============

Since the first *in vitro* fertilization-embryo transfer (IVF-ET) baby was born in 1978, IVF-ET procedures have made remarkable progress, and various assisted reproductive technologies have been implemented. Unfortunately, the routine embryo selection method used during the IVF-ET procedure remains unsatisfactory; thus, most IVF centers induce a higher pregnancy rate by implanting more than one embryo. Multiple ET increases the chance of conception from IVF, but it is associated with an increased chance of multiple pregnancies \[[@B1]\]. Multiple pregnancies have been reported to result in obstetrical and neonatal complications, such as congenital malformations, low birth weight with intrauterine growth retardation, and cesarean sections \[[@B2][@B3]\]. The elective transfer of a single embryo has been suggested as the most efficient approach to avoid multiple pregnancies \[[@B4]\]. Therefore, embryo selection is a very important process before ET. Embryo selection based on a morphological assessment at a few points in time has several limitations for single ET. Images of the embryo provide more accurate data to guide embryo selection \[[@B5][@B6]\].

Time-lapse monitoring systems enable the detailed evaluation of morphology, including dynamic parameters, and they allow the exclusion of negative factors, such as multi-nucleation of the blastomere and irregular division. Several methods have been proposed for culturing embryos using a time-lapse incubator to maintain a stable environment. Observation of embryos in a time-lapse incubator can provide useful information about embryonic developmental events if images are automatically captured \[[@B7][@B8][@B9][@B10]\].

In 1997, Payne et al. \[[@B11]\] developed the first time-lapse system for studying morphokinetics in human embryos. This system overcame the limitations of intermittent observation. Their research group has described the timing of the morphological events of fertilization, including extrusion of the polar body and formation of the pronucleus, using their video recording system.

Approximately 10 years later, Mio \[[@B12]\] developed a new system for time-lapse monitoring, that maintains optimal stable culture conditions for long periods, based on the report of Payne et al. \[[@B11]\]. This new technique can take more than 2,000 images during the early stages of human embryonic development and provides useful information about embryonic development after intracytoplasmic sperm injection (ICSI) for approximately 40 hours, when embryos reach the 2 to 4 cell stage. Formation of the morula and blastocyst hatching were successfully monitored *in vitro* for 2 to 5 days \[[@B13]\].

In a more recent study, a model was developed to predict embryo implantation based on the timing and characteristics of cleavage events, further underscoring the usefulness of continued embryo observation \[[@B10]\].

The intrinsic difference between ICSI and IVF is known to affect the zygote and to affect embryo development in general \[[@B14][@B15]\]. IVF requires a sperm cell to penetrate the cumulus cells and the zona pellucida, but ICSI can induce insemination without certain processes taking place. Moreover, ICSI is more invasive than conventional IVF. For example, ICSI oocytes are exposed to hyaluronidase and intense light during the denuding process and are damaged by mechanical pipetting \[[@B16]\].

It was found that ICSI-fertilized 4-cell embryos spent approximately 2.5 hours less time in the 2-cell stage than IVF-fertilized 4-cell embryos, and that the 3-cell stage was longer in ICSI-fertilized oocytes \[[@B7]\]. In addition, the first cleavage has been reported to be slow in conventional IVF \[[@B17]\]. However, the small sample size used in those two studies limits the analysis of the morphokinetics of embryo cleavage, making it difficult to compare insemination techniques.

This study compared insemination methods (IVF and ICSI) to determine whether they had different effects on morphokinetics and abnormal cleavage events in embryonic development.

Methods
=======

1. Patients and design
----------------------

This study included 272 cycles of IVF/ICSI treatment from June 2013 to March 2015 at Maria Fertility Hospital. The study was approved by the Institutional Review Board of Maria Fertility Hospital (No. 2016-005). The patients included had no chromosomal diseases and had normal karyotypes.

2. Ovarian stimulation and oocyte retrieval
-------------------------------------------

Women were treated with a gonadotropin-releasing hormone agonist (Superfact; Sanofi-Aventis, Frankfurt, Germany) using the long protocol or a gonadotropin-releasing hormone antagonist protocol and recombinant follicle-stimulating hormone (Gonal F; Merck Serono, Darmstadt, Germany). When two or more follicles reached 18 mm in diameter, 10,000 IU of human chorionic gonadotropin (hCG) (IVF-C; LG Chemical, Seoul, Korea) or Ovidrel (Merck Serono) was administered.

3. Conventional IVF
-------------------

IVF insemination was performed by adding 1×10^6^ spermatozoa/mL. Fertilization was assessed 16 to 18 hours after insemination and confirmed based on the presence of two pronuclei and two polar bodies. Fertilized embryos were cultured using a pre-equilibrated EmbryoSlide (Unisense FertiliTech, Aarhus, Denmark).

4. Intracytoplasmic sperm injection
-----------------------------------

ICSI was usually performed when the sperm sample was poor, based on the embryologist\'s judgment and following the World Health Organization criteria of sperm concentration \<15×10^6^/mL, motility \<40%, and strict morphology \<4%.

After removing the cumulus cell attached to the egg with MRC\#ICSI (Biosupply, Seoul, Korea) containing 0.1% hyaluronidase (Biosupply), the collected oocytes were cultured in Sydney IVF fertilization medium (Cook, Brisbane, Australia). ICSI was performed using an inverted Nikon microscope (TE 2000 U; Nikon, Kawasaki, Japan) equipped with a manipulator (Narishige, Tokyo, Japan). Sperm selection was performed under ×200 to ×400 magnification, and microinjection of each oocyte was performed as described by Kim et al. \[[@B18]\]. Once injected, the oocytes were placed in individual wells of a pre-equilibrated EmbryoSlide (Unisense FertiliTech).

5. Culture and annotation using time-lapse monitoring
-----------------------------------------------------

For culture with the EmbryoScope (Vitrolife, Goteborg, Sweden), dedicated 12-well plates were prepared with 25-µL microdrops of Sydney IVF cleavage medium (Cook) overlaid by 1.4 mL of mineral oil (Biosupply) at 37℃ in 6% CO~2~, 5% O~2~, and 89% N~2~. The surplus embryos developed to the blastocyst stage were vitrified by the electron microscopy-grid method following artificial shrinkage of the blastocoel \[[@B19]\].

Images of each embryo were analyzed retrospectively using the EmbryoViewer external image analysis software (Unisense FertiliTech). Images were acquired every 20 minutes in seven different focal planes during culture \[[@B10]\]. Embryonic developmental events were annotated with the corresponding timing in units of hours after IVF and ICSI. Annotations included the time to faded pronuclei (tPNf), the times to a 9-cell embryo (t2, t3, t4, t5, t6, t7, t8, and t9), time to formation of a morula (tM), initiation of blastulation (tSB), the formation of the blastocyst (tB), and time taken to complete the maximal blastocyst expansion (tEB). Cell cycle durations were calculated for the second cell cycle (cc2, t3--t2), the third cell cycle (cc3, t5--t3), the synchrony of the second cell cycle (s2, t4--t3), and the synchrony of the third cell cycle (s3, t8--t5). Additionally, abnormal cleavage events, multinucleation, and the good-quality embryo rate per embryo on day 3 were investigated. Good-quality embryos were defined as having 8 to 10 cells, no embryo fragmentation, and cells that were very even, regular, and similarly sized.

6. Confirmation of pregnancy
----------------------------

If β-hCG was detected in the blood 14 days after egg collection, the trace test after 1 week showed a continuous increase, and vaginal ultrasonography performed at 6 to 7 weeks of pregnancy showed a gestational sac, then clinical pregnancy was verified. The implantation rate was calculated as the percentage of embryonic sacs implanted in the uterus that became implanted embryos. Miscarriage was defined as a fetal loss prior to 12 weeks of gestation despite the presence of a gestational sac in the first-trimester ultrasound.

7. Statistical analysis
-----------------------

Statistical analysis was performed with SPSS ver. 12.0 (SPSS Inc., Chicago, IL, USA). Quantitative data are presented as the mean±standard deviation, and properties are shown for categorical variables. The Student *t*-test was used to compare continuous variables, and the chi-square test was used for discrete variables. The *p*-values \<0.05 were considered to indicate statistical significance.

Results
=======

This study included 272 cycles of IVF/ICSI treatments (122 conventional IVF and 150 ICSI). When the characteristics of the IVF cycles were compared with those of the ICSI cycles, no significant differences were found in female age, body mass index, basal follicle-stimulating hormone, previous assisted reproductive technology cycles, or endometrial thickness ([Table 1](#T1){ref-type="table"}). Comparisons of the clinical outcomes between the two groups are presented in [Table 2](#T2){ref-type="table"}. No significant differences were observed between the two groups with regard to the retrieved oocytes, fertilization rate, the high-quality embryo rate on day 3, and the number of transferred embryos. Furthermore, no significant differences were found between IVF and ICSI regarding the clinical pregnancy rate (57.4% vs. 52.0%), implantation rate (33.2% vs. 30.5%), or miscarriage rate (15.1% vs. 16.3%) ([Table 2](#T2){ref-type="table"}).

ICSI-derived embryos developed significantly faster than those produced with conventional IVF at tPNf (25.2±4.2 hours vs. 24.3±3.9 hours, *p*\<0.001), t2 (28.1±4.8 hours vs. 27.0±4.5 hours, *p*\<0.001), t3 (37.1±6.1 hours vs. 36.5±5.7 hours, *p*=0.021), t4 (39.4±6.2 hours vs. 38.7±5.8 hours, *p*=0.016), t5 (49.9±8.8 hours vs. 46.7±7.9 hours, *p*=0.005), and t6 (53.4±9.6 hours vs. 52.4±8.5 hours, *p*=0.030). However, no significant differences were found from t7 to tEB between the two groups. The cell cycle of cc2 was not different, but the IVF group (12.9±6.3 hours vs. 11.9±6.9 hours, *p*=0.001) had a longer cycle than ICSI for cc3. No statistically significant differences were observed in the synchrony of the cell cycles (s1, s2, and s3) ([Table 3](#T3){ref-type="table"}).

We compared abnormal cleavage events in embryonic development. There were no differences between the two groups in the rates of direct cleavage from 1 to 3 cell (*p*=0.149), 2 multinucleated cells (*p*=0.691), 2 uneven cells (*p*=0.463), or reverse cleavage (*p*=0.884) ([Table 4](#T4){ref-type="table"}).

Discussion
==========

This study is the largest retrospective study reported to date on the analysis of morphokinetic events and negative cleavage events associated with different insemination methods. In particular, this paper is the first to study the development of human embryos using a time-lapse system in Korea. The ICSI-based method selects one of the most suitable sperm cells based on morphology and motility under a microscope, and that sperm cell is injected into the cytoplasm of an oocyte to induce insemination. This method helps to overcome male infertility. However, a number of concerns have been raised about artificially removing the cumulus cells surrounding the oocyte and manipulating the oocyte while injecting the sperm cell into its cytoplasm. These hormonal and mechanical manipulations may have detrimental effects on subsequent embryo development and pregnancy \[[@B16]\]. In particular, compared to a cryo-IVF group, a higher major malformation rate was reported in a cryo-ICSI group \[[@B20]\], but this result is controversial.

Previous studies have reported that the initial development of ICSI-derived embryos progressed faster than that of IVF-derived embryos. The 2-cell stage of the IVF embryos was 13 hours, compared to 10.5 hours for ICSI. Additionally, the 3-cell stage of ICSI embryos was 1.3 hours shorter than that of IVF embryos \[[@B7]\]. This suggests that IVF-derived embryos had higher synchrony during the second cleavage than ICSI-derived embryos. In one reported case, the 2-cell stage of IVF embryos (10.3 hours) was shorter than that of ICSI embryos (10.6 hours) \[[@B7]\]. However, according to a study that analyzed embryos that developed to late blastocysts within the 2-cell to 8-cell stages, ICSI not only had a faster t2, but also a faster t3 than standard IVF. Although ICSI showed faster development up to the 3-cell stage, there was no difference between the two groups from the 4-cell to 8-cell stages. Statistically significant differences were not found in the synchrony between s2 and s3 of the cell cycle \[[@B17]\]. This is similar to our results, which showed no significant differences between s2 and s3.

In our study comparing the developmental stages of IVF and ICSI, we found that the cleavage rate of ICSI was faster than that of IVF at tPNF, t2, t3, t4, t5, and t6. Although no difference in cc2 was found, a significant difference in cc3 was found between IVF and ICSI (12.9 hours vs. 11.9 hours, *p*\<0.05).

In a retrospective study of 1,203 cleavage-stage embryos inseminated based on the oocyte donation model \[[@B21]\], the cleavage rate of ICSI was found to be slightly faster than that of IVF at tPNF, t2, t5, t7, and t9. A sperm cell must pass through cumulus cells and the zona pellucida to fuse with the oolemma for insemination to occur in conventional IVF, whereas ICSI bypasses such processes. These differences in the process explain why IVF embryos have a slower initial development time than ICSI embryos.

The major developmental events and implantation rates were studied using time-lapse imaging \[[@B22]\], and it was found that the 2- to 3-cell stages lasted for less than 5 hours in approximately 14% of embryos. The implantation rate was low, approximately 1% to 2%, when these embryos were used for transplantation. For this reason, direct cleavage from 1 to 3 cells could be considered as an exclusion criterion \[[@B10]\]. In a retrospective study of 834 embryos using different insemination methods, differences in direct cleavage were tested \[[@B21]\]; ICSI-derived embryos had a higher direct-cleavage rate than IVF-derived embryos (11.1% vs. 10.0%, respectively), but the result was not statistically significant. Interestingly our study was different in that IVF-derived embryos showed a slightly higher direct-cleavage rate than ICSI-derived embryos (23.4% vs. 20.6%, respectively), but the difference was likewise not statistically significant.

IVF-ET has made a leap forward. The introduction of time-lapse techniques has made it possible to observe embryonic development, detect abnormal cleavage events, and respond with clinical treatments. Multinucleated blastomeres result from abnormal cleavage and may be detrimental to late embryonic development or clinical outcomes, and they are a key criterion that cannot be excluded from the embryo grading system \[[@B23]\]. Previous studies have reported that multinucleated blastomeres increased the aneuploidy rate and decreased the implantation rate \[[@B24][@B25][@B26]\]. Another retrospective study of 2-cell multinucleated embryos and non-multinucleated embryos was performed on 550 patients, and the results showed that multinucleated embryos had a lower clinical pregnancy rate (23.4% vs. 44.0%) and a lower implantation rate (23.3% vs. 43.6%) than non-multinucleated embryos. The multinucleated blastomeres had worse clinical outcomes \[[@B27]\]. However, in our study, no significant difference was found between the IVF and ICSI groups with regard to 2-cell multinucleation events or clinical outcomes.

Uneven blastomere cleavage and other major abnormalities are known to have negative effects on clinical outcomes. According to a retrospective study performed on 378 transplanted embryos \[[@B28]\], uneven blastomere cleavage was associated with a lower pregnancy rate (37.6% vs. 52.9%, respectively) and a lower implantation rate (23.9% vs. 36.4%, respectively) than even blastomere cleavage. In our comparative study of ICSI and IVF, there was no significant difference in the incidence of uneven blastomere cleavage between the two groups, and there was no difference in the clinical outcomes. This is the first study to report the incidence of even blastomere cleavage using a time-lapse system.

In conclusion, ICSI bypasses a specific process that is included in conventional IVF, which results in a differentiation process that is 1 hour faster on average until the 6-cell stage. However, no significant differences were observed from that point until the blastocyst stage. Additionally, no significant differences in abnormal cleavage events, such as direct cleavage, the multinucleation of 2 cells, and uneven blastomere cleavage, were found between the ICSI and IVF groups, which explains why no significant differences were found in the clinical outcomes between the two groups.
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###### Characteristics of the patients
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Values are mean±standard deviation.

IVF, *in vitro* fertilization; ICSI, intracytoplasmic sperm injection; BMI, body mass index; FSH, follicle-stimulating hormone; AMH, anti-Müllerian hormone; ART, assisted reproductive technology; GnRH, gonadotropin-releasing hormone.

###### Comparison of laboratory and clinical outcome measures according to the fertilization method
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Values are presented as mean±standard deviation or number (%).

IVF, *in vitro* fertilization; ICSI, intracytoplasmic sperm injection.

###### Comparison of time-lapse parameters according to the fertilization method
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t0, insemination time; IVF, *in vitro* fertilization; ICSI, intracytoplasmic sperm injection; SD, standard deviation; tPNf, time to faded pronuclei; t2, time to 2 cells; t3, time to 3 cells; t4, time to 4 cells; t5, time to 5 cells; t6, time to 6 cells; t7, time to 7 cells; t8, time to 8 cells; t9, time to 9 cells; tM, time to formation of a morula; tSB, time to initiation of blastulation; tB, time to the formation of the blastocyst; tEB, time taken to complete the maximal blastocyst expansion.

###### Abnormal early cleavage events
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Values are presented as number (%).

IVF, *in vitro* fertilization; ICSI, intracytoplasmic sperm injection.
